Myasthenia Gravis
NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016
Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease
Neurol 97:e1367-e1381, Gaig, C.,et al, 2021
Clinical Manifestations of the anti-IgLON5 Disease
Neurol 88:1736-1743,1688, Gaig, C.,et al, 2017
HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
NEJM 364:1134-1143, McCormack,M.,et al, 2011
HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
NEJM 364:1126-1133, Chen,P.,et al, 2011
Interaction Between HLA-DR2 and Abnormal Brain MRI in Optic neuritis and Early MS
Neurol 54:1859-1861, Hauser,S.L.,et al, 2000
Behcet's Disease
NEJM 341:1284-1291, Sakane,T.,et al, 1999
Optic Neuritis, Prognosis for Multiple Sclerosis from MRI, CSF, and HLA Findings
Neurol 50:708-714, Soderstrom,M.,et al, 1998
Fisher Syndrome after Campylobacter Jejuni Enteritis:Human Leukocyte Antigen and the Bacterial Serotype
J Pediatr 126:55-57, Yuki,N.,et al, 1995
Human Leukocyte Antigens in Fisher's Syndrome
Ann Neurol 33:655-657, Yuki,N.,et al, 1993
Narcolspey
NEJM 323:389-394, Aldrich,M.S., 1990
Risk Factors for Multiple Sclerosis:Race or Place? Editorial
JNNP 53:821-823, 903, 906990., Compston,A., 1990